Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice
Abstract Diabetes is a complex disease characterized by hyperglycemia, dyslipidemia, and insulin resistance. Plasma advanced glycation end products (AGEs) activated the receptor for advanced glycation end products (RAGE) and the activation of RAGE is implicated to be the pathogenesis of type 2 diabe...
Guardado en:
Autores principales: | Chih-Pei Lin, Po-Hsun Huang, Chi-Yu Chen, Meng-Yu Wu, Jia-Shiong Chen, Jaw-Wen Chen, Shing-Jong Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a91ccdc0d60a4a68ac60662d9f835fc8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
por: Wen-Pin Huang, et al.
Publicado: (2021) -
Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma S, et al.
Publicado: (2019) -
Advanced Glycation End-Products in Skeletal Muscle Aging
por: Lucas C. Olson, et al.
Publicado: (2021) -
The impact of endothelial progenitor cells on restenosis after percutaneous angioplasty of hemodialysis vascular access.
por: Chih-Cheng Wu, et al.
Publicado: (2014) -
Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
por: Tássia Kirchmann Lazzari, et al.
Publicado: (2021)